This bill amends the Pharmacy Act to establish provisions for custodial care facilities regarding the acquisition and possession of controlled substances specifically for withdrawal management. It introduces a new section that allows licensed custodial care facilities, which provide medically monitored withdrawal management under the supervision of a consulting pharmacist and have nursing staff available 24/7, to acquire, stock, and maintain dangerous drugs, including controlled substances.

The bill defines "controlled substance" as any drug, substance, or immediate precursor listed in Schedules III and V of the Controlled Substances Act. This legislative change aims to enhance the capabilities of custodial care facilities in managing withdrawal processes safely and effectively, ensuring that they have the necessary medications available for patient care.